CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 16 enrolled
Drug / intervention
single-fraction SRS +2 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02320825
NCT02320825Phase 3Completed
CompareCT.gov

Phase III Multicenter Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases

Memorial Sloan Kettering Cancer Center·interventional·Posted Dec 19, 2014·Updated Feb 19, 2019

In Brief

A Phase 3 clinical trial evaluating single-fraction SRS, high-dose hypofractionated SRS, and 1 other intervention for Spinal Metastases. Completed, enrolled 16 participants across 4 sites.

Detailed Summary

The purpose of this study is to find out whether giving one higher dose of radiation is as good at treating the tumor in the patient's spine after surgery as giving three lower doses of radiation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Metastases
CountriesUnited States
CollaboratorsJohns Hopkins University, Massachusetts General Hospital, Stanford University

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 19, 2014
Enrollment StartDec 16, 2014
Primary CompletionJul 26, 2018
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 11.5 years ago

Interventions

single-fraction SRSradiation

high-dose hypofractionated SRSradiation

Quality of Life Measuresbehavioral